Insulin Pricing Legislation

Rod discusses the impact of HR 40813, known as Mats Act, on insulin pricing. The bill aims to cap insulin costs at $50-$60 for the uninsured and $0 for those with high deductible plans. This episode sheds light on the complexities of the insulin industry and the potential relief this legislation could bring to millions.